BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9193532)

  • 1. Prevention of primary nonfunction after porcine islet allotransplantation.
    Liu X; Hering BJ; Mellert J; Brandhorst D; Brandhorst H; Federlin K; Bretzel RG; Hopt UT
    Transplant Proc; 1997 Jun; 29(4):2071-2. PubMed ID: 9193532
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of functional xenograft tolerance of pig islets in the autoimmune NOD mouse.
    Thomas FT; Pittman K; Thomas JM
    Transplant Proc; 1995 Dec; 27(6):3323-5. PubMed ID: 8539973
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of 15-deoxyspergualin on islet allograft survival in the canine model.
    Wahoff D; Papalois B; Leone J; Aasheim T; Gilmore T; Sutherland DE
    Transplant Proc; 1996 Apr; 28(2):912. PubMed ID: 8623458
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of porcine islet allograft survival.
    Liu X; Hering BJ; Mellert J; Brandhorst D; Brandhorst H; Federlin K; Bretzel RG; Hopt UT
    Transplant Proc; 1997; 29(1-2):768-9. PubMed ID: 9123518
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of primary nonfunction of xenograft islets.
    Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
    Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous glucose tolerance tests after porcine islet auto- and allotransplantation.
    Mellert J; Hering BJ; Liu X; Brandhorst D; Brandhorst H; Federlin K; Bretzel RG; Hopt UT
    Transplant Proc; 1997 Jun; 29(4):2091-2. PubMed ID: 9193541
    [No Abstract]   [Full Text] [Related]  

  • 8. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression.
    Henretta J; McFadden T; Pittman K; Thomas J; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861
    [No Abstract]   [Full Text] [Related]  

  • 9. Extended survival of purified canine islet allografts with heterologous antilymphocyte globulin.
    Kaufman DB; Morel P; Field MJ; Roney M; Condie R; Sutherland DE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):761-3. PubMed ID: 1990682
    [No Abstract]   [Full Text] [Related]  

  • 10. Pig-to-human islet transplantation in eight patients.
    Tibell A; Groth CG; Möller E; Korsgren O; Andersson A; Hellerström C
    Transplant Proc; 1994 Apr; 26(2):762-3. PubMed ID: 8171652
    [No Abstract]   [Full Text] [Related]  

  • 11. Xenotransplantation of bovine islets into the thymus of totally pancreatectomized pigs.
    Carmellini M; Del Guerra S; Solari R; Marchetti P; Bellissima G; Meacci L; Burchielli S; Giannarelli R; Calabrese M; Navalesi R; Mosca F
    Transplant Proc; 1998 Aug; 30(5):2478-80. PubMed ID: 9723546
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful long-term pancreatic islet cell xenotransplantation and functional tolerance in NOD mice.
    Ljung T; Pittman K; Thomas FT
    Transplant Proc; 1995 Feb; 27(1):1351-2. PubMed ID: 7878908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy.
    Pittman K; Thomas F; McFadden T; Haisch C; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):986-7. PubMed ID: 8442292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of xenograft resistance to autoimmune disease recurrence after pancreas islet transplantation.
    Thomas F; Pittman K; Larkin E; Berzina P; Contreras J; Quarantillo P; Thomas J
    Transplant Proc; 1999; 31(1-2):964-5. PubMed ID: 10083429
    [No Abstract]   [Full Text] [Related]  

  • 15. Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure.
    Oberholzer J; Toso C; Triponez F; Ris F; Bucher P; Demirag A; Lou J; Majno P; Buehler L; Philippe J; Morel P
    Transplant Proc; 2002 May; 34(3):823-5. PubMed ID: 12034197
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
    Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
    Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraportal islet allografts in type I diabetes mellitus.
    Alejandro R; Burke G; Shapiro ET; Strasser S; Nery J; Ricordi C; Esquenazi V; Miller J; Mintz DH
    Transplant Proc; 1992 Jun; 24(3):959-60. PubMed ID: 1604685
    [No Abstract]   [Full Text] [Related]  

  • 18. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts.
    Henretta J; Pittman K; McFadden T; Thomas J; Thomas F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs.
    Wahoff DC; Stephanian E; Gores PF; Soon-Shiong P; Hower C; Lloveras JK; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):804. PubMed ID: 8171668
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of primary nonfunction in discordant pancreas islet xenografts.
    Pittman K; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.